Last friday (10/11), we presented our neurotoxicity and genotoxicity assays at the French Agency for Food and Safety (ANSES). The ANSES had organized a meeting between different public screening platform facilities,  who used high content screening technologies.

We were kindly invited to present our platforms, and how HCS Pharma is involved in the development of innovative assays. Those events are a good way to start new collaborations, and we want to thanks Kevin Hogeveen, from Fougères laboratory who organized this meeting.